Evidence map›Paper›PMID 42199349›Full record

ArticleExperimental and therapeutic medicine2026

Glycolytic reprogramming in host response to

Yan Dong, Yantong Chen, Yanshuang Luo, Meng Liu, Chao Song, Xuesong Chen, Fusong Yang, Qingyi Luo, Guozhong Zhou

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Experimental and therapeutic medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yan DongFaculty of Life Science and Technology and The Affiliated Anning First People's Hospital, Kunming University of Science and Technology, Kunming, Yunnan 650302, P.R. China.
Yantong ChenFaculty of Life Science and Technology and The Affiliated Anning First People's Hospital, Kunming University of Science and Technology, Kunming, Yunnan 650302, P.R. China.
Yanshuang LuoFaculty of Life Science and Technology and The Affiliated Anning First People's Hospital, Kunming University of Science and Technology, Kunming, Yunnan 650302, P.R. China.
Meng LiuFaculty of Life Science and Technology and The Affiliated Anning First People's Hospital, Kunming University of Science and Technology, Kunming, Yunnan 650302, P.R. China.
Chao SongDepartment of Pain Medicine, The Affiliated Anning First People's Hospital of Kunming University of Science and Technology, Kunming, Yunnan 650302, P.R. China.
Xuesong ChenDepartment of Pain Medicine, The Affiliated Anning First People's Hospital of Kunming University of Science and Technology, Kunming, Yunnan 650302, P.R. China.
Fusong YangDepartment of Pain Medicine, The Affiliated Anning First People's Hospital of Kunming University of Science and Technology, Kunming, Yunnan 650302, P.R. China.
Qingyi LuoDepartment of Ultrasound, Yanan Hospital of Kunming City, The Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650302, P.R. China.
Guozhong ZhouSchool of Basic Medical Sciences, Kunming University of Science and Technology, Kunming, Yunnan 650500, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lyme disease (LD), a multifaceted condition caused by

Indexed as

bioinformaticsBorrelia burgdorferigene expression omnibus databaseglycolytic geneimmune cell infiltrationpotential drugs

Identifiers

PMID42199349
PMCPMC13199952

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.